ValueAct Capital Management LP

Managed by ValueAct Capital. $4.0M disclosed long-equity portfolio across 17 positions.

#StockValue% of Portfolio
1REUTERS GROUP PLC$954K23.66%
2SARA LEE CORP$531K13.18%
3MDS INC$422K10.48%
4GARTNER GROUP INC NEW-CL A$365K9.06%
5EQUIFAX INC$278K6.90%
6OMNICARE INC$269K6.67%
7WARNER CHILCOTT LIMITED$261K6.47%
8ADVANCED MEDICAL OPTICS INC$216K5.36%
9VALEANT PHARMACEUTICALS INTL$158K3.93%
10MOODYS CORP$138K3.43%
11CHOICEPOINT INC$126K3.13%
12ACXIOM CORP$121K3.01%
13INTL RECTIFIER CORP$82K2.02%
14SEALY CORPORATION$44K1.08%
15GEVITY HR INC$25K0.63%
16NABORS INDUSTRIES LTD$22K0.55%
17CHIMERA INVESTMENT CORPORATION$18K0.44%

For full quarterly history, transactions, and the investor profile, see ValueAct Capital's page →

More related to Valueact Capital 0001351069

ValueAct Capital Management LP — overview

ValueAct Capital runs ValueAct Capital Management LP, a multi-strategy investment firm tracked here via SEC 13F filings. As of the Q4 2007 13F filing, the disclosed long-equity portfolio is valued at $4M across 17 positions. The largest holdings are REUTERS GROUP PLC, SARA LEE CORP, and MDS INC (REUTERS GROUP PLC alone is 23.7% of the book).

Key takeaways

  • Disclosed Q4 2007 portfolio: $4M.
  • Top holdings: REUTERS GROUP PLC, SARA LEE CORP, and MDS INC.